Targeting WT1 in hematologic malignancies? Journal Article
| Author: | Koehne, G. |
| Article Title: | Targeting WT1 in hematologic malignancies? |
| Abstract: | In this issue of Blood, Tawara et al report the first results of a novel treatment approach with T-cell receptor transduced autologous T cells targeting a restricted Wilms’ tumor 1 (WT1)-derived epitope in patients with refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).1 © 2017 by The American Society of Hematology. |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | 18 |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-11-02 |
| Start Page: | 1959 |
| End Page: | 1960 |
| Language: | English |
| DOI: | 10.1182/blood-2017-09-805358 |
| PROVIDER: | scopus |
| PUBMED: | 29097369 |
| DOI/URL: | |
| Notes: | Note -- Export Date: 4 December 2017 -- Source: Scopus |
